Bgm (BGM) Accumulated Expenses (2019 - 2025)
Bgm's (BGM) quarterly Accumulated Expenses came in at $27.4 million in Q3 2025, up 2892.6% year-on-year from $915032.0 in Q3 2024, and up 265.7% on a QoQ basis from $7.5 million in Q1 2025.
Bgm (BGM) Accumulated Expenses (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Accumulated Expenses data on file, last reported at $27.4 million in Q3 2025.
- On a quarterly basis, Accumulated Expenses rose 2892.6% year-over-year to $27.4 million in Q3 2025; TTM through Sep 2025 was $27.4 million, a 2892.6% increase from a year earlier, with the FY2025 full-year figure at $27.4 million, up 2892.6% from the prior year.
- Accumulated Expenses for Q3 2025 stood at $27.4 million, up from $7.5 million in the prior quarter.
- Over the last five years, Accumulated Expenses for BGM reached as high as $733.5 billion in Q1 2023 and fell as low as $466838.0 in Q3 2021.
- Historically, Accumulated Expenses has averaged $134.8 billion across 5 years, with a median of $1.2 million in 2023.
- Across the five-year window, Accumulated Expenses sank 100.0% in 2024 and surged 2892.6% in 2025, its largest moves.
- Year by year, Accumulated Expenses stood at $466838.0 in 2021, then surged by 50.22% to $701263.0 in 2022, then jumped by 71.91% to $1.2 million in 2023, then retreated by 24.1% to $915032.0 in 2024, then jumped by 2892.6% to $27.4 million in 2025.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $27.4 million in Q3 2025, $7.5 million in Q1 2025, and $915032.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27.38 Mn |
| Mar 31, 2025 | 7.49 Mn |
| Sep 30, 2024 | 915,032.00 |
| Mar 31, 2024 | 1.20 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 733.49 Bn |
| Sep 30, 2022 | 701,263.00 |
| Mar 31, 2022 | 479.73 Bn |
| Sep 30, 2021 | 466,838.00 |
| Sep 30, 2020 | 1.30 Mn |
| Sep 30, 2019 | 531,713.00 |